Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Relative contraindicationsconditions requiring closer monitoring or specialist inputinclude significant kidney impairment, active gastrointestinal disease, recent bariatric surgery, or concurrent use of certain medications that affect satiety or glucose metabolism
According to the FDA-approved prescribing information, gastrointestinal adverse reactions (nausea, vomiting, diarrhea) occur in up to 43% of patients taking Mounjaro and 37% of patients taking Zepbound, with higher rates during dose escalation phases
RETA treatment improved metabolic factors, boosted anti-tumor immunity, and potently blunted tumor progression in non-obesity associated lung adenocarcinoma Based on the dramatic findings in PDAC, an obesity-associated cancer, we were interested in whether RETA could also be effective in a non-obesity associated cancer
Its level decreases with age (especially from the age of 45-50) and as the body's defence needs increase (immunity, liver detoxification, antioxidant defences...)
